Pipeline

Overview

 

CMC/
Nonclinical

IND/IDE

Phase 1

Phase 2

Phase 3/
Pivotal

NDA/PMA

Market
 Rx
AST-726              
Vitamin B12 deficiency - 505(b)(2)    
Hedrin®              
Head lice    
AST-915*              
Essential tremor      
 OTC
 

Evaluation

Manufacturing/Packaging

Registration

Market

Topical GEL

        

Mild psoriasis

    
 
 = completed  = ongoing/in process  = next steps

 

*NIH sponsored IND currently open and Phase I safety/efficacy study underway under joint corporate/NIH CRADA Agreement.  Corporate IND will need to be filed prior to progression to Phase II/III